These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4808468)

  • 61. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals.
    Mukhopadhyay A; Patel ST; O'Brien M; Kokrady SS; Newman HA; Witiak DT; Lanese RR; Rice JC; Feller DR
    Lipids; 1983 Jan; 18(1):59-67. PubMed ID: 6835036
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ascorbic acid and drug metabolism.
    Zannoni VG; Flynn EJ; Lynch M
    Biochem Pharmacol; 1972 May; 21(10):1377-92. PubMed ID: 4402218
    [No Abstract]   [Full Text] [Related]  

  • 63. Relationship of serum triglyceride lowering to changes in hepatic composition induced by different classes of drugs.
    Dalton C; Hope WC; Hope HR; Sheppard H
    Biochem Pharmacol; 1974 Feb; 23(3):685-96. PubMed ID: 4150813
    [No Abstract]   [Full Text] [Related]  

  • 64. Some selected studies on hepatic microsomal drug-metabolizing enzymes--environment interactions.
    Fouts JR
    Drug Metab Dispos; 1973; 1(1):380-5. PubMed ID: 4149408
    [No Abstract]   [Full Text] [Related]  

  • 65. Polychlorinated biphenyls as phenobarbitone-type inducers of microsomal enzymes. Structure-activity relationships for a series of 2,4-dichloro-substituted congeners.
    Denomme MA; Bandiera S; Lambert I; Copp L; Safe L; Safe S
    Biochem Pharmacol; 1983 Oct; 32(19):2955-63. PubMed ID: 6414484
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of methylxanthines on aniline disappearance and metabolism in rats.
    Aeschbacher HU
    Experientia; 1975 Aug; 31(8):894-6. PubMed ID: 1157848
    [No Abstract]   [Full Text] [Related]  

  • 67. [Relation between chemical structure of quinoxalines disubstituted at the 2,3-positions and the enzymatic detoxication activity in rat liver microsomes].
    Beraud M; Gaillard D; Derache R
    Biochem Pharmacol; 1975 Aug; 24(16):1505-9. PubMed ID: 1191308
    [No Abstract]   [Full Text] [Related]  

  • 68. Development of liver microsomal oxidations in the chick.
    Powis G; Drummond AH; Macintyre DE; Jondorf WR
    Xenobiotica; 1976 Feb; 6(2):69-81. PubMed ID: 1274375
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of the effects of halothane and CCl 4 on the hepatic drug metabolizing system.
    Davis DC; Schroeder DH; Gram TE; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1971 Jun; 177(3):556-66. PubMed ID: 4398189
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of chronic ethanol administration in the rat: relative dependency on dietary lipids--I. Induction of hepatic drug-metabolizing enzymes in vitro.
    Joly JG; Hétu C
    Biochem Pharmacol; 1975 Aug; 24(16):1475-80. PubMed ID: 811224
    [No Abstract]   [Full Text] [Related]  

  • 71. Effect of microsomal preparations and induction on cytochrome P-450-dependent monooxygenases in fetal and neonatal rat liver.
    Cresteil T; Flinois JP; Pfister A; Leroux JP
    Biochem Pharmacol; 1979 Jul; 28(13):2057-63. PubMed ID: 224884
    [No Abstract]   [Full Text] [Related]  

  • 72. Evidence for spironolactone as a possible inducer of liver microsomal enzymes in mice.
    Gerald MC; Feller DR
    Biochem Pharmacol; 1970 Aug; 19(8):2529-32. PubMed ID: 5520611
    [No Abstract]   [Full Text] [Related]  

  • 73. Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid).
    Gibson GG; Orton TC; Tamburini PP
    Biochem J; 1982 Apr; 203(1):161-8. PubMed ID: 7103935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structure-activity relationships on the induction of hepatic microsomal enzymes in the mouse by 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane(DDT) analogs.
    Abernathy CO; Hodgson E; Guthrie FE
    Biochem Pharmacol; 1971 Sep; 20(9):2385-93. PubMed ID: 4147778
    [No Abstract]   [Full Text] [Related]  

  • 75. Reversibility of hepatic changes caused by ethoxyquin.
    Parke DV; Rahim A; Walker R
    Biochem Pharmacol; 1974 Jul; 23(13):1871-6. PubMed ID: 4376401
    [No Abstract]   [Full Text] [Related]  

  • 76. Sex and strain differences in basal and induced aniline hydroxylase and ethylmorphine N-demethylase activities from domestic and wild rats.
    Page JG; Vesell ES
    Pharmacology; 1969; 2(6):321-36. PubMed ID: 5362408
    [No Abstract]   [Full Text] [Related]  

  • 77. Ethanol-a direct inducer of drug metabolism.
    Kalant H; Khanna JM; Lin GY; Chung S
    Biochem Pharmacol; 1976 Feb; 25(3):337-42. PubMed ID: 1267830
    [No Abstract]   [Full Text] [Related]  

  • 78. Differential distribution of the mixed-function oxidase activities in rabbit kidney.
    Zenser TV; Mattammal MB; Davis BB
    J Pharmacol Exp Ther; 1978 Dec; 207(3):719-25. PubMed ID: 731427
    [No Abstract]   [Full Text] [Related]  

  • 79. The effect of a polychlorinated biphenyl (Aroclor 1254) on liver microsomal enzymes in the male rat.
    Turner JC; Green RS
    Bull Environ Contam Toxicol; 1974 Dec; 12(6):669-71. PubMed ID: 4156182
    [No Abstract]   [Full Text] [Related]  

  • 80. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene.
    Poland A; Glover E
    Mol Pharmacol; 1974 Mar; 10(2):349-59. PubMed ID: 4851117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.